CN108186888A - 一种具有降低血糖功能的中药组合物及其制备方法 - Google Patents
一种具有降低血糖功能的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN108186888A CN108186888A CN201810209979.1A CN201810209979A CN108186888A CN 108186888 A CN108186888 A CN 108186888A CN 201810209979 A CN201810209979 A CN 201810209979A CN 108186888 A CN108186888 A CN 108186888A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- preparation
- medicine composition
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 239000008103 glucose Substances 0.000 title claims abstract description 41
- 210000004369 blood Anatomy 0.000 title claims abstract description 32
- 239000008280 blood Substances 0.000 title claims abstract description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 20
- 241000219781 Pueraria montana var. lobata Species 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 235000019441 ethanol Nutrition 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 8
- 238000002386 leaching Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000004503 fine granule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 229960003943 hypromellose Drugs 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 230000009467 reduction Effects 0.000 abstract description 6
- 230000035622 drinking Effects 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 4
- 230000010354 integration Effects 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 33
- 238000002474 experimental method Methods 0.000 description 29
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
- 230000006870 function Effects 0.000 description 15
- 241001570521 Lonicera periclymenum Species 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 241000700159 Rattus Species 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 12
- 238000003304 gavage Methods 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 229920002527 Glycogen Polymers 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 229940096919 glycogen Drugs 0.000 description 8
- 230000002440 hepatic effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 229960004580 glibenclamide Drugs 0.000 description 5
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 5
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 3
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000837 restrainer Substances 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810209979.1A CN108186888B (zh) | 2018-03-14 | 2018-03-14 | 一种具有降低血糖功能的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810209979.1A CN108186888B (zh) | 2018-03-14 | 2018-03-14 | 一种具有降低血糖功能的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108186888A true CN108186888A (zh) | 2018-06-22 |
CN108186888B CN108186888B (zh) | 2021-04-13 |
Family
ID=62595796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810209979.1A Active CN108186888B (zh) | 2018-03-14 | 2018-03-14 | 一种具有降低血糖功能的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186888B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229265A (zh) * | 2007-12-12 | 2008-07-30 | 北京神舟祥瑞医药科技发展有限公司 | 一种降糖及降脂药物组合物及其制备方法 |
CN103211972A (zh) * | 2013-04-11 | 2013-07-24 | 天津天狮生物发展有限公司 | 一种补肾组合物及其制备方法 |
-
2018
- 2018-03-14 CN CN201810209979.1A patent/CN108186888B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229265A (zh) * | 2007-12-12 | 2008-07-30 | 北京神舟祥瑞医药科技发展有限公司 | 一种降糖及降脂药物组合物及其制备方法 |
CN103211972A (zh) * | 2013-04-11 | 2013-07-24 | 天津天狮生物发展有限公司 | 一种补肾组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
《健康大讲堂》编委会: "《糖尿病怎么吃蔬果》", 30 September 2015, 黑龙江科学技术出版社 * |
田胜利等: "《控制糖尿病不得不说的秘密》", 31 October 2017, 中国中医药出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN108186888B (zh) | 2021-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101095751B (zh) | 具有祛黄褐斑、改善营养性贫血的药物组合物及制备方法 | |
WO2015172608A1 (zh) | 一种辅助降血脂的胶囊及其制备方法 | |
CN106074971A (zh) | 一种降血糖中药组合物及制备方法与应用 | |
CN103861086A (zh) | 一种苦瓜肽阿拉伯糖复合片的制作方法 | |
CN107997176A (zh) | 一种防治小儿积食厌食的健胃消食保健食品 | |
CN104548061A (zh) | 对化学性肝损伤有辅助保护功效的组合物及其制备方法 | |
CN100594924C (zh) | 一种降血脂的中药组合物及其制备方法 | |
CN114042126B (zh) | 升清化浊利湿益气减肥降脂中药组合物及其制剂制备方法 | |
CN107801985A (zh) | 含山药、白扁豆、鸡内金、山楂的中药组合物及其应用 | |
CN1813819B (zh) | 猴头子实体或猴头菌丝体及培养物提取物及制剂和制法 | |
CN104922216B (zh) | 一种通便的药物组合物及其制备方法 | |
CN104383447B (zh) | 一种中药药物组合物及其制备方法与应用 | |
CN101856418B (zh) | 防治肾炎的药物制剂及其制备方法 | |
CN111543635A (zh) | 一种具有减肥功能的保健食品及其制备方法 | |
CN108186888A (zh) | 一种具有降低血糖功能的中药组合物及其制备方法 | |
CN103920140A (zh) | 一种人用降糖减肥降脂复方制剂 | |
CN100428951C (zh) | 一种降血糖的保健食品 | |
CN106421741A (zh) | 水溶性橄榄叶提取物保健品及其制备方法 | |
CN102048132B (zh) | 一种用于降血糖的保健食品 | |
CN104173734B (zh) | 一种治疗糖调节受损的药物组合物及其制备方法 | |
CN108186876A (zh) | 一种具有降低血糖功能的中药组合物及其制备方法 | |
CN104664011B (zh) | 一种具有清咽保健功能的组合物及其制备方法 | |
CN108157969A (zh) | 一种补血养颜组合物及其制备方法 | |
CN108904596A (zh) | 一种具有改善记忆力功效的组合物 | |
CN115779046B (zh) | 一种防治糖尿病的中药组合物、中药制剂与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ruan Shaoping Inventor after: Li Jing Inventor after: Ding Ziqin Inventor after: Huo Meixin Inventor after: Zhang Aixia Inventor after: Sun Wei Inventor before: Li Jing Inventor before: Ding Ziqin Inventor before: Huo Meixin Inventor before: Zhang Aixia Inventor before: Sun Wei |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210329 Address after: 518000 room 704, building 5, Fulian garden, 5011 Hongli Road, Futian District, Shenzhen City, Guangdong Province Applicant after: Ruan Shaoping Address before: 473300 No.18 dalisong, Houcao village, Jinzhuang Town, Sheqi County, Nanyang City, Henan Province Applicant before: Li Jing Applicant before: Ding Ziqin Applicant before: Huo Meixin Applicant before: Zhang Aixia Applicant before: Sun Wei Applicant before: CAMOD BIOLOGICAL TECHNOLOGY (TIANJIN) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |